deferiprone Capsules 500 mg

This CTD dossier owner and manufacturer is a quality-driven, customer-centric pharmaceutical manufacturer specializing in generic finished dosage formulations. A subsidiary of a multinational group headquartered in Southeast Asia, it boasts an annual turnover exceeding US$150 million and operates as both a contract manufacturer for global MNCs and a producer of its own branded medications. The company emphasizes affordability and accessibility, aiming to meet unmet patient needs. Their focus lies on developing products across multiple therapy areas, utilizing various dosage forms. They possess GMP certifications and hold patents for their products. While primarily based in South Asia, they aim to expand their reach into the EU and North America through strategic partnerships and collaborations.